A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Clermont Oncology Center ( Site 0041), Clermont, Florida, United States

University of Illinois Hospital & Health Sciences System ( Site 0044), Chicago, Illinois, United States

Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0282), Barretos, São Paulo, Brazil

Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0286), São José do Rio Preto, São Paulo, Brazil

Hospital Paulistano ( Site 0280), São Paulo, São Paulo, Brazil

Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0162), Santiago, Region M. de Santiago, Chile

FALP ( Site 0161), Santiago, Region M. de Santiago, Chile

Bradfordhill ( Site 0160), Santiago, Region M. de Santiago, Chile

Guangdong Provincial People s Hospital ( Site 0300), Guangzhou, Guangdong, China

THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 0204), Athens, Attica, Greece

Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 0205), Athens, Attica, Greece

Queen Mary Hospital ( Site 0230), Hong Kong, Hong Kong

Shaare Zedek Medical Center ( Site 0186), Jerusalem, Israel

Sheba Medical Center ( Site 0180), Ramat Gan, Israel

Severance Hospital, Yonsei University Health System ( Site 0080), Seoul, South Korea

Institut Català d'Oncologia - L'Hospitalet ( Site 0090), Hospitalet, Barcelona, Spain

Hospital Clinic de Barcelona ( Site 0092), Barcelona, Spain

Hospital Universitario Virgen Macarena ( Site 0093), Seville, Spain